Telesair is a medical technology startup founded in 2020 that develops compact and mobile respiratory care solutions. The company's primary focus is on enabling earlier patient discharge from hospitals to home settings, aiming to improve outcomes for individuals with respiratory insufficiency.
Company Values
The company stands out by designing and manufacturing its cost-effective and user-friendly High Flow Oxygen Therapy (HFOT) system in the United States, led by veterans from the respiratory industry. Telesair achieved rapid regulatory success, obtaining both an MDR CE Mark and FDA clearance for its primary product in less than one year.